葡萄牙儿童在PCV13纳入国家免疫规划后的肺炎链球菌携带、血清型、基因型及抗菌药物耐药趋势:一项横断面研究
该横断面研究于2018—2020年在葡萄牙日托儿童中采集1450份鼻咽样本,评估PCV13纳入国家免疫规划后的肺炎链球菌携带、血清型、耐药及基因型,并与PCV13前及早期、晚期PCV13时期比较。结果显示携带率稳定在60.2%,PCV13血清型携带降至10.7%,但青霉素低水平耐药和大环内酯类耐药升至约20%,主要因非PCV13血清型谱系扩张。
要点
- 2018—2020年日托儿童肺炎链球菌携带率为60.2%,PCV13血清型携带降至10.7%。
- 未接种儿童和4—6岁儿童更易携带PCV13血清型,分别为2.5倍(95%CI 1.1-5.6)和2.9倍(95%CI 1.3-6.8)。
- 青霉素低水平耐药和大环内酯类耐药均升至约20%,主要来自表达非PCV13血清型的谱系。
核心结论
- 肺炎链球菌种群正在适应PCV13和抗菌药物使用带来的压力,需保持密切监测。
研究设计与样本
- 横断面研究,2018—2020年从葡萄牙日托儿童(≤6岁)采集1450份鼻咽样本,并与2009—2010年(PCV13前)、2011—2012年(早期PCV13)、2015—2016年(晚期PCV13)比较。
主要发现
- 肺炎链球菌携带率稳定在60.2%,PCV13血清型携带为10.7%,较PCV13前时期的47.6%显著下降。
- 最常见的PCV13血清型19F、3和19A较PCV13前时期均显著下降:19F从7.1%降至4.7%,3从10.1%降至1.8%,19A从14.1%降至1.8%。
- 未接种儿童携带PCV13血清型的可能性为2.5倍(95%CI 1.1-5.6),4—6岁儿童为2.9倍(95%CI 1.3-6.8)。
- 最常见的非PCV13血清型为15B/C、11A、23B、23A和NT,合计占所有分离株的51.9%;30.5%的肺炎链球菌可被PCV20覆盖。
- 青霉素低水平耐药和大环内酯类耐药从晚期PCV13时期的9.3%和13.4%分别升至约20%,主要来自表达非PCV13血清型的谱系,接近PCV13前水平。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Streptococcus pneumoniae carriage studies are crucial to monitor changes induced by use of pneumococcal conjugate vaccines and inform vaccination policies. In this cross-sectional study, we examined changes within the pneumococcal population following introduction of PCV13 in 2015 in the National Immunization Program (NIP), in Portugal. In 2018-2020 (NIP-PCV13), we obtained 1450 nasopharyngeal samples from children ≤6 years attending day-care. We assessed serotypes, antimicrobial resistance, and genotypes (MLST and GPSC) and compared findings with earlier periods: 2009-2010 (pre-PCV13), 2011-2012 (early-PCV13), and 2015-2016 (late-PCV13). Pneumococcal carriage prevalence remained stable at 60.2 %. Carriage of PCV13 serotypes was 10.7 %, markedly reduced compared to pre-PCV13 period (47.6 %). The most prevalent PCV13 serotypes were 19F, 3, and 19A all showing a significant decreasing trend compared to the pre-PCV13 period (from 7.1 % to 4.7 %, 10.1 % to 1.8 %, and 14.1 % to 1.8 %, respectively), a notable observation given the described limited effectiveness of PCV13 against serotype 3. Non-vaccinated children and children aged 4-6 years were more likely to carry PCV13 serotypes (2.5-fold, 95 %CI [1.1-5.6], and 2.9-fold, 95 %CI [1.3-6.8], respectively). The most prevalent non-PCV13 serotypes were 15B/C, 11A, 23B, 23A, and NT, collectively accounting for 51.9 % of all isolates. In total, 30.5 % of all pneumococci were potentially covered by PCV20. Resistance to penicillin (low-level) and macrolides increased significantly, from 9.3 % and 13.4 %, respectively, in the late-PCV13 period, to approximately 20 % each, mostly due to lineages expressing non-PCV13 serotypes, nearing pre-PCV13 levels. An expansion of lineages traditionally associated with PCV13 serotypes, like CC156-GPSC6 (serotype 14) and CC193-GPSC11 (serotype 19F), but now predominantly expressing non-PCV13 serotypes (11A, 15B/C, and 24F for GPSC6; and 15A and 21 for GPSC11) was noted. These findings indicate that the pneumococcal population is adapting to the pressures conferred by PCV13 and antimicrobial use and indicate the need to maintain close surveillance.
引用
- Candeias C, Almeida ST, Paulo AC, et al. Streptococcus pneumoniae carriage, serotypes, genotypes, and antimicrobial resistance trends among children in Portugal, after introduction of PCV13 in National Immunization Program: A cross-sectional study. Vaccine. 2024. PMID: 39146858. doi:10.1016/j.vaccine.2024.126219
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。